5-year Follow-up of a Randomized Controlled Trial of Immediate versus Delayed Zoledronic Acid for Prevention of Bone Loss in Postmenopausal Women with Breast Cancer Starting Letrozole after Tamoxifen: N03CC (Alliance)
- Citation:
- Cancer vol 121 (15) 2537-2543
- Year:
- 2015
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Long-Term-Followup
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pmc-release
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- 4
- Parents:
- None
- Children:
- None
- Program:
- CCP
- Primary Committee:
- Symptom Inter
- Sec. Committees:
- Pharmas:
- Grants:
- N01 CA035431, U10 CA035269, CA-37404, U10 CA031946, U10 CA033601, U10 CA037404, U10 CA180821, CA-35103, CA-25224, UG1 CA189823, P30 CA015083, U10 CA035415, CA-35415, U10 CA035431, UG1 CA189808, CA-35269, U10 CA025224, U10 CA035103
- Corr. Author:
- Nina D. Wagner-Johnston
- Authors:
- Nina D. Wagner-Johnston Jeff A. Sloan Heshan Liu Ann E. Kearns Stephanie L. Hines Suneetha Puttabasavaiah Shaker R. Dakhil Jacqueline M. Lafky Edith A. Perez Charles L. Loprinzi
- Networks:
- KS055, LAPS-MD017, LAPS-MN026, PR028
- Study
- NCCTG-N03CC
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords:
- zoledronic acid, bone loss, postmenopausal, breast cancer, letrozole, tamoxifen